Elevated Liver Enzymes (ELE) often present a diagnostic challenge for clinicians due to the myriad of potential causes. This brief review aims to provide a comprehensive approach to the diagnosis and management of ELE.
Diagnosis of ELE begins with a thorough history and physical examination. Key factors to consider include alcohol consumption, medication use, and exposure to hepatotoxic substances. Laboratory investigations should include a complete liver panel, coagulation studies, and serologic tests for viral hepatitis.
Management of ELE primarily focuses on addressing the underlying cause. This may involve lifestyle modifications, medication changes, or specific treatments for identified liver diseases. Close monitoring of liver function tests is essential to assess response to treatment and detect any potential complications.
Imaging studies, such as ultrasound or CT scan, can provide valuable information about the liver's structure and help identify conditions such as fatty liver disease or cirrhosis. However, these should be reserved for cases where initial investigations are inconclusive.
Diagnosing and managing ELE requires a systematic approach that includes thorough history taking, appropriate laboratory and imaging investigations, and targeted treatment strategies. By adopting such an approach, clinicians can effectively manage this common clinical dilemma.
1.
A Lot Can Be Said About You by Including Yourself in Photos.
2.
A new blood test greatly increases the ability to detect cancer.
3.
Novel biomarker has potential for predicting and treating skin cancer metastasis
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
1.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
2.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
3.
Contemporary Frameworks in Oncology Across Clinical Settings
4.
What is Mullerian and How Does it Affect Your Health
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Common Causes of Abnormal Blood Counts
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Understanding Cancer: Early Detection and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation